• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Association Between Metabolic Syndrome and Prostate Cancer Risk: A Large-Scale Investigation and Study of Chinese.代谢综合征与前列腺癌风险的关联:一项基于中国人群的大规模研究
Front Endocrinol (Lausanne). 2022 May 20;13:787268. doi: 10.3389/fendo.2022.787268. eCollection 2022.
2
The association of metabolic syndrome and its components with serum prostate-specific antigen levels.代谢综合征及其组分与血清前列腺特异性抗原水平的关系。
Eur J Cancer Prev. 2020 Jan;29(1):36-41. doi: 10.1097/CEJ.0000000000000508.
3
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.剖析代谢综合征与前列腺癌风险之间的关联:一项大型临床队列研究分析。
Eur Urol. 2015 Jan;67(1):64-70. doi: 10.1016/j.eururo.2014.01.040. Epub 2014 Feb 14.
4
Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.前列腺增大部分掩盖了代谢综合征对血清前列腺特异性抗原水平的实际降低作用:一项基于大规模人群研究的结果
BJU Int. 2017 Oct;120(4):482-489. doi: 10.1111/bju.13621. Epub 2016 Aug 28.
5
Metabolic Syndrome is Associated with Prostate Cancer Diagnosed on Biopsy but not the Gleason Score and the Number of Cancer-Positive Cores: A Prospective Controlled Study.代谢综合征与前列腺癌诊断时的活检相关,但与格里森评分和癌阳性核心数无关:一项前瞻性对照研究。
Arch Esp Urol. 2023 Sep;76(7):504-510. doi: 10.56434/j.arch.esp.urol.20237607.62.
6
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.代谢综合征样组分与前列腺癌风险:度他雄胺降低前列腺癌事件(REDUCE)研究的结果
BJU Int. 2015 May;115(5):736-43. doi: 10.1111/bju.12843. Epub 2014 Oct 20.
7
Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.代谢综合征和低高密度脂蛋白胆固醇与接受根治性前列腺切除术治疗的前列腺癌患者的不良病理特征相关。
Urol Oncol. 2018 Feb;36(2):80.e17-80.e24. doi: 10.1016/j.urolonc.2017.09.026. Epub 2017 Nov 16.
8
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study.在接受耻骨后根治性前列腺切除术的患者中,代谢综合征与晚期前列腺癌相关:一项多中心前瞻性研究的结果
BMC Cancer. 2016 Jul 7;16:407. doi: 10.1186/s12885-016-2442-7.
9
Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.高分期和高分级临床前列腺癌男性患者的临床、血流动力学、人体测量学、代谢及胰岛素谱
Blood Press. 2004;13(1):47-55. doi: 10.1080/08037050310025735.
10
The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.直肠指检在肥胖患者前列腺癌检测中作为诊断试验的作用。
J BUON. 2015 Nov-Dec;20(6):1601-5.

引用本文的文献

1
Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders.用于预测代谢紊乱男性前列腺肿瘤的综合药物遗传学特征
Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):285-305. doi: 10.21873/cgp.20502.
2
Association between the metabolic score for insulin resistance and prostate cancer: a cross-sectional study in Xinjiang.胰岛素抵抗代谢评分与前列腺癌的相关性:新疆的一项横断面研究。
PeerJ. 2024 Jul 26;12:e17827. doi: 10.7717/peerj.17827. eCollection 2024.
3
Role of Metabolism and Metabolic Pathways in Prostate Cancer.代谢及代谢途径在前列腺癌中的作用
Metabolites. 2023 Jan 25;13(2):183. doi: 10.3390/metabo13020183.

本文引用的文献

1
Endocrinology of the Aging Prostate: Current Concepts.前列腺增龄的内分泌学:当前概念。
Front Endocrinol (Lausanne). 2021 Feb 22;12:554078. doi: 10.3389/fendo.2021.554078. eCollection 2021.
2
Meta-analysis of metabolic syndrome and prostate cancer.代谢综合征与前列腺癌的荟萃分析。
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):146-155. doi: 10.1038/pcan.2017.1. Epub 2017 Feb 21.
3
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?代谢综合征与癌症:代谢综合征在预测癌症风险方面,除其各个组成部分外是否具有额外的作用?
Diabetes Metab. 2015 Dec;41(6):463-9. doi: 10.1016/j.diabet.2015.04.006. Epub 2015 May 30.
4
The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.接受根治性前列腺切除术的中国患者中代谢综合征与晚期前列腺癌的关联。
Asian J Androl. 2015 Sep-Oct;17(5):839-44. doi: 10.4103/1008-682X.148138.
5
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.代谢综合征样组分与前列腺癌风险:度他雄胺降低前列腺癌事件(REDUCE)研究的结果
BJU Int. 2015 May;115(5):736-43. doi: 10.1111/bju.12843. Epub 2014 Oct 20.
7
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.剖析代谢综合征与前列腺癌风险之间的关联:一项大型临床队列研究分析。
Eur Urol. 2015 Jan;67(1):64-70. doi: 10.1016/j.eururo.2014.01.040. Epub 2014 Feb 14.
8
Minireview: the molecular and genomic basis for prostate cancer health disparities.小型综述:前列腺癌健康差异的分子和基因组基础
Mol Endocrinol. 2013 Jun;27(6):879-91. doi: 10.1210/me.2013-1039. Epub 2013 Apr 22.
9
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.代谢综合征与绝经后乳腺癌:系统评价和荟萃分析。
Menopause. 2013 Dec;20(12):1301-9. doi: 10.1097/GME.0b013e31828ce95d.
10
Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.代谢综合征及其组分对前列腺癌风险的影响:荟萃分析。
J Endocrinol Invest. 2013 Feb;36(2):132-9. doi: 10.1007/BF03346748.

代谢综合征与前列腺癌风险的关联:一项基于中国人群的大规模研究

The Association Between Metabolic Syndrome and Prostate Cancer Risk: A Large-Scale Investigation and Study of Chinese.

机构信息

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, China.

Department of Health Management Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Endocrinol (Lausanne). 2022 May 20;13:787268. doi: 10.3389/fendo.2022.787268. eCollection 2022.

DOI:10.3389/fendo.2022.787268
PMID:35669684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9164813/
Abstract

BACKGROUND

To investigate the association between metabolic syndrome (MetS) and its components and prostate cancer (PCa).

METHODS

This study enrolled 482 943 consecutive men who underwent routine health checkups at the Health Management Center of West China Hospital Between 2010 and 2017. For patients with elevated prostate-specific antigen (PSA) levels or color Doppler ultrasound indicating abnormal prostates, we recommended prostate puncture and follow-up. We used the chi-square test and independent t-test for categorical variables and continuous variables, respectively. We used logistic regression analysis to evaluate the effects of MetS and its components on prostate cancer risk.

RESULTS

We found that the incidence of PCa in Chinese men over 40 years of age was 0.1%. Among the 85882 participants, 31.5% (27016/85882) of the patients were diagnosed with MetS. PCa was associated with older age, higher PSA levels, lighter weight and shorter height, hypertension, elevated fasting blood glucose (FBG) and HDL cholesterol level, lower triglycerides. After excluded the interference of other factors in multivariate logistic analysis, we found that MetS, hypertension, hyperlipidemia, hyperglycemia, and obesity were not related to the risk of PCa. High age and PSA levels were risk factors for prostate cancer.

CONCLUSIONS

High age and PSA levels were risk factors for prostate cancer. MetS, hypertension, hyperlipidemia, hyperglycemia, and obesity were not related to the risk of PCa.

摘要

背景

研究代谢综合征(MetS)及其各组分与前列腺癌(PCa)之间的相关性。

方法

本研究纳入了 2010 年至 2017 年在华西医院健康管理中心接受常规健康检查的 482943 例连续男性患者。对于前列腺特异性抗原(PSA)水平升高或彩色多谱勒超声示前列腺异常的患者,我们建议进行前列腺穿刺和随访。我们分别使用卡方检验和独立 t 检验来比较分类变量和连续变量。使用 logistic 回归分析来评估 MetS 及其各组分对前列腺癌风险的影响。

结果

我们发现中国 40 岁以上男性的 PCa 发病率为 0.1%。在 85882 名参与者中,31.5%(27016/85882)的患者被诊断为 MetS。PCa 与年龄较大、较高的 PSA 水平、较轻的体重和较短的身高、高血压、空腹血糖(FBG)和高密度脂蛋白胆固醇水平升高、甘油三酯水平降低有关。在多变量 logistic 分析排除其他因素的干扰后,我们发现 MetS、高血压、高脂血症、高血糖和肥胖与 PCa 风险无关。高龄和 PSA 水平是前列腺癌的危险因素。

结论

高龄和 PSA 水平是前列腺癌的危险因素。MetS、高血压、高脂血症、高血糖和肥胖与 PCa 风险无关。